Cassava Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAVA and other ETFs, options, and stocks.About SAVA
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.
CEORichard Jon Barry
CEORichard Jon Barry
Employees30
Employees30
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1998
Founded1998
Employees30
Employees30
SAVA Key Statistics
Market cap175.84M
Market cap175.84M
Price-Earnings ratio-1.42
Price-Earnings ratio-1.42
Dividend yield—
Dividend yield—
Average volume9.07M
Average volume9.07M
High today$3.75
High today$3.75
Low today$3.42
Low today$3.42
Open price$3.47
Open price$3.47
Volume3.90M
Volume3.90M
52 Week high$33.98
52 Week high$33.98
52 Week low$1.15
52 Week low$1.15
SAVA News
TipRanks 3d
Top Executive Makes Bold Move with Major Stock Purchase in Cassava SciencesNew insider activity at Cassava Sciences ( (SAVA) ) has taken place on October 2, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 5...
People also own
Based on the portfolios of people who own SAVA. This list is generated using Robinhood data, and it’s not a recommendation.